|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
licensing of medicines
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
monitoring adverse drug reactions
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
recall of unsafe products
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
authorisation of medicines
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
adverse event reporting
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
monitoring of product safety
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
pharmacovigilance
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
clinical trial approval
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
enforcement of regulations
|
|
gptkb:CIMA_(Cayman_Islands)
|
market conduct supervision
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
inspecting manufacturers and distributors
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
clinical trial authorisation
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
public health protection
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
licensing medicines
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
vigilance reporting
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
medical device safety
|
|
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
enforcing regulations
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
recall of unsafe products
|
|
gptkb:UK_Medicines_and_Healthcare_products_Regulatory_Agency
|
inspection and enforcement
|
|
gptkb:Pelmorex_Corp.
|
operator of Canada's National Alert Aggregation and Dissemination System (NAAD)
|